Biava; Mariangela

Patent Applications and Registrations

Patent applications and USPTO patent grants for Biava; Mariangela.The latest application filed is for "1,5-diaryl-2-alkylpyrrole-3-substituted nitro esters, selective cox-2 inhibitors and nitric oxide donors".

Company Profile

0.6.6

Biava; Mariangela - Rome N/A IT
Biava; Mariangela - Roma IT
Biava; Mariangela - Siena IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors Grant 9,162,979 - Giordani , et al. October 20, 2	2015-10-20
1,5-Diaryl-2-alkylpyrrole-3-Substituted Nitro Esters, Selective COX-2 Inhibitors and Nitric Oxide Donors App 20130165494 - Giordani; Antonio ; et al.	2013-06-27
Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto Grant 8,304,410 - Biava , et al. November 6, 2	2012-11-06
Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiper- azine, synthesis process and uses thereof Grant 8,012,970 - Biava , et al. September 6, 2	2011-09-06
Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof App 20110144109 - BIAVA; Mariangela ; et al.	2011-06-16
Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl] methyl}-4-methylpiperazine, synthesis process and uses thereof Grant 7,910,581 - Biava , et al. March 22, 2	2011-03-22
3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors Grant 7,906,551 - Cappelli , et al. March 15, 2	2011-03-15
Pyrrole Compounds As Inhibitors Of Mycobacteria, Synthesis Thereof And Intermediates Thereto App 20100197672 - Biava; Mariangela ; et al.	2010-08-05
Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof App 20090281094 - Biava; Mariangela ; et al.	2009-11-12
3-substituted-1,5-diarly-2-alkyl-pyrroles Highly Selective And Orally Effective Cox-2 Inhibitors App 20090264500 - Cappelli; Andrea ; et al.	2009-10-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.